How Guava Extracts May Help Combat Fluconazole-Resistant Candida Infections

Jim Crocker
1st July, 2024

How Guava Extracts May Help Combat Fluconazole-Resistant Candida Infections

Bioactive compounds from the Guava fruit (Psidium guajava, pictured) are identified in this study as promising agents for overcoming fluconazole resistance in Candida albicans by targeting a key drug efflux pump.

Photo adapted from: Jo Roberts / CC BY (Source)

Key Findings

  • Researchers at Saveetha University studied fluconazole-resistant Candida albicans from root caries specimens
  • They found that 65% of the samples contained C. albicans, with two strains resistant to fluconazole
  • Psidium guajava (guava) extract showed promising antifungal activity against these resistant strains
Candida albicans is a common fungal pathogen that can exist harmlessly in various parts of the human body, such as the intestine, urogenital tract, and skin. However, under certain conditions, it can become opportunistic, leading to infections. A recent study conducted by Saveetha University aimed to address a growing concern: the resistance of C. albicans to fluconazole, a commonly used antifungal drug[1]. The study focused on isolating C. albicans from root caries specimens and evaluating the effectiveness of bioactive compounds from Psidium guajava (commonly known as guava) against fluconazole-resistant strains. This research is particularly relevant given the increasing prevalence of drug-resistant Candida strains, which complicates treatment options[2]. Researchers collected 20 carious scrapings from patients with root caries and screened them for the presence of C. albicans. They found that 65% of the samples contained C. albicans, and two of these strains were resistant to fluconazole. To understand the genetic basis of this resistance, the team performed molecular characterization of two genes, Cdrp1 and Cdrp2, known to be involved in drug resistance through PCR amplification. The study also explored the potential of Psidium guajava methanolic extract as an alternative treatment. The extract demonstrated promising antifungal activity against the fluconazole-resistant strains. This finding is significant because it opens the door to new, plant-based treatments for fungal infections that are becoming increasingly difficult to manage with conventional drugs. To delve deeper into the mechanism, the researchers conducted in-silico docking studies. In-silico docking is a computational method used to predict how molecules, such as drugs, interact with target proteins. They focused on an opaque-phase ABC transporter protein, which is involved in drug resistance. The docking simulations revealed that Myricetin, a bioactive compound found in Psidium guajava, had a high docking score and favorable interactions with the ABC transporter protein. This study builds on previous research that has shown the complexity of Candida infections and their resistance mechanisms. For instance, Candida albicans is known to undergo various morphogenetic changes and has a viable haploid state that can facilitate mating and genetic diversity[3]. These characteristics contribute to its adaptability and resistance to antifungal treatments. Moreover, the study aligns with broader research on the oral microbiome, which highlights the importance of a balanced microbial community in maintaining oral health. Disruptions in this balance can lead to overgrowth of pathogenic species like C. albicans, resulting in infections[4]. The findings from Saveetha University suggest that Psidium guajava could help restore this balance by targeting resistant strains of Candida. The implications of this research are significant. By identifying a natural compound that can combat fluconazole-resistant C. albicans, the study offers a potential new avenue for treatment. However, the researchers caution that further in-vivo studies are necessary to validate these findings and assess their practical application in improving oral health and hygiene. In conclusion, the study from Saveetha University provides promising evidence that bioactive compounds from Psidium guajava could be effective against fluconazole-resistant strains of Candida albicans. This research not only contributes to our understanding of fungal resistance but also opens up new possibilities for natural, plant-based treatments in combating difficult-to-treat infections.

MedicineBiotechMycology

References

Main Study

1) Computational Evaluation on the Interactions of an Opaque-Phase ABC Transporter Associated with Fluconazole Resistance in Candida albicans, by the Psidium guajava Bio-Active Compounds.

Published 30th June, 2024

https://doi.org/10.3831/KPI.2024.27.2.91

Related Studies

2) Candidiasis and Mechanisms of Antifungal Resistance.

https://doi.org/10.3390/antibiotics9060312

3) The 'obligate diploid' Candida albicans forms mating-competent haploids.

https://doi.org/10.1038/nature11865

4) Functional biomes beyond the bacteriome in the oral ecosystem.

https://doi.org/10.1016/j.jdsr.2022.05.002


Related Articles

An unhandled error has occurred. Reload 🗙